Join BioCelerate for its second meeting of the BioCelerate Preclinical Collaboration Forum, which brings together cross-industry stakeholders to advance conversation and innovation in preclinical research.
During this forum industry leaders will address the following topics:
- How virtual controls may play a role in a reduce, reuse, recycle strategy (3R)
- Considerations to ensure the scientific validity of study designs
- Likely challenges or barriers to success and potential ways to overcome them
Featured panelists include:
- Esther Vock, Director of Special Toxicology, (Genetic Toxicology, Immunotoxicology & Data Sciences), Boehringer Ingelheim Pharmaceuticals; Governing Council, BioCelerate
- Kevin Snyder, Associate Director of Nonclinical Informatics, U.S. Food & Drug Administration
- Thomas Steger-Hartmann, Head of Investigational Toxicology, Vice President, Bayer AG Pharmaceuticals
- Lars Mecklenburg, Site Managing Director & Executive Safety Assessment, Labcorp
- Laura Lotfi, Translational Sciences & Data Analytics Manager, Charles River
Attendees of the BioCelerate Collaboration Forum include representatives from:
- Sponsors
- Health Authorities
- CROs
- Industry Groups